- In December 2023, HiMedia Laboratories introduced its HiGenoMB RT-PCR kits, capable of detecting the JN.1 variant of SARS-CoV-2. This variant, a descendant of the BA.2.86 (Pirola) strain of Omicron, has been identified as a variant of concern due to its immune-escape capabilities, which are contributing to a rise in cases worldwide
- In September 2022, the FDA granted 510(k) clearance to DiaSorin’s Simplexa COVID-19 Direct kit, marking a significant advancement in the battle against the COVID-19 pandemic. This approval enables the detection of the SARS-CoV-2 virus using nasal or nasopharyngeal swab samples. Designed for use with the LIAISON MDX platform, a molecular diagnostic system recognized for its efficiency and accuracy, the kit enhances testing capabilities
- In January 2022, Roche Diagnostics India introduced a new COVID-19 At-Home Test, an over-the-counter test designed to detect SARS-CoV-2 infection in individuals experiencing COVID-19 symptoms. This test provides the convenience of at-home testing, offering a quick and accessible option for those who suspect they may have contracted the coronavirus
- In June 2022, Genes2Me launched the CoviEasy Self-Test Rapid Antigen test kit for COVID-19 in India, offering an easy-to-use solution that delivers faster results in just 10 minutes. Backed by an AI-driven Mobile App, this IVD product ensures a high level of sensitivity and a concordance rate of over 98% accuracy
